Prescriptions issued in the EEA and Switzerland: guidance for pharmacists
Guidance for pharmacists on prescriptions issued in EU countries, Norway, Iceland, Liechtenstein and Switzerland.
Latest change: Updated with guidance for pharmacists when dispensing an EEA or Swiss prescription now the Brexit transition period has ended, including details about the prescribing-approved countries and professions list.
AI Summary
Starting January 1, 2021, the UK Medicines and Healthcare products Regulatory Agency (MHRA) updated guidelines for dispensing prescriptions issued in the European Economic Area (EEA) and Switzerland. Governed by Regulation 214(6A) of the Human Medicines Regulations 2012, this framework allows UK pharmacists to fulfill prescriptions from approved countries if the prescriber belongs to a recognized profession, such as doctors, dentists, or nurses. Pharmacists must verify the prescriber’s identity, credentials, and contact details against an officially maintained list. Key restrictions remain in place: pharmacists are prohibited from dispensing any controlled drugs (Schedules 1-3) or unlicensed 'specials' against EEA or Swiss prescriptions. These prescriptions must be treated as private transactions for reimbursement purposes. Required actions for pharmacists include checking the approved country and profession lists and exercising professional discretion regarding the clinical appropriateness and authenticity of the document. If a prescription does not meet these criteria, pharmacists should refuse service and assist the patient in contacting local UK health services to obtain a valid domestic prescription. Emergency supplies of medicines are still permitted under specific recognized conditions.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.